GlassScriptPhysician profile
Kent R Nilsson
NPI 1619965381
$198,275.55
in general payments reported to CMS, 2019-2025
35 companies · $42K in 2025
The $42K reported for 2025 was more than what 94% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,420 · 2020: $12K · 2021: $2,227 · 2022: $73K · 2023: $23K · 2024: $40K · 2025: $42K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $72K · Travel and Lodging: $14K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $11K · Food and Beverage: $9,079.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $71,904.93 |
| Travel and Lodging | $13,618.19 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $11,400.00 |
| Food and Beverage | $9,078.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $157,485.62 | 2019-2025 | Aveir, Tacticath Ablation Catheter, Sensor Enabled, Ensite |
| Biosense Webster, INC. | $18,263.66 | 2022-2025 | Carto 3 |
| Cortex, INC. | $11,673.40 | 2024 | |
| Altathera Pharmaceuticals LLC | $2,893.55 | 2021-2024 | Sotalol Hydrochloride |
| Boston Scientific Corporation | $2,765.12 | 2021-2025 | Watchman Flx, Optimap System - Na, Watchman Access System |
| Medtronic, INC. | $1,324.01 | 2024-2025 | Evera Mri Xt Dr Surescan, Cobalt Dr Mri Surescan, Micra |
| Medtronic Vascular, INC. | $612.37 | 2019-2020 | |
| Cardiva Medical, INC. | $503.61 | 2020-2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Amgen INC. | $426.11 | 2019-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $380.13 | 2019-2025 | |
| Atricure, INC. | $365.79 | 2019-2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $290.69 | 2020-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $190.11 | 2019-2024 | Xarelto |
| Ablacon, INC. | $160.93 | 2022 | |
| Shockwave Medical, INC | $142.96 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $102.05 | 2019-2025 | Farxiga, Lokelma |
| Vektor Medical INC. | $101.21 | 2025 | Vmap |
| Irhythm Technologies, INC. | $72.37 | 2020-2024 | Zio Xt Patch, Zio Monitor |
| E.R. Squibb & Sons, L.L.C. | $62.68 | 2022-2023 | Camzyos |
| Chiesi USA, INC. | $57.84 | 2021-2024 | Kengreal |
| Sanofi-Aventis U.S. LLC | $57.54 | 2021-2024 | |
| Pfizer INC. | $47.83 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $47.76 | 2021-2024 | Verquvo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $44.62 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $32.31 | 2022-2025 | |
| Cvrx, INC. | $28.57 | 2020-2023 | Barostim Neo System |
| Angiodynamics, INC. | $26.90 | 2021 | |
| Abiomed | $21.81 | 2025 | |
| Cordis US Corp. | $18.81 | 2024 | Mynx Control |
| B. Braun Interventional Systems INC. | $18.07 | 2020 | |
| Volta Medical INC | $16.03 | 2024 | Vx1 |
| Ethicon US, LLC | $15.26 | 2020 | |
| Novo Nordisk INC | $14.32 | 2024 | Ozempic |
| Alnylam Pharmaceuticals INC. | $11.51 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kent Nilsson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.